Commonwealth Equity Services
OCUL icon

Commonwealth Equity Services’s Ocular Therapeutix OCUL Stock Holding History

Commonwealth Equity Services’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Buy
19,417
+8,970
+86% +$81.3K ﹤0.01% 4143
2026
Q1 		$88.5K Sell
10,447
-141
-1% -$1.34K ﹤0.01% 4150
2025
Q4 		$129K Buy
10,588
+231
+2% +$2.81K ﹤0.01% 4074
2025
Q3 		$121K Sell
10,357
-4,003
-28% -$47.9K ﹤0.01% 4055
2025
Q2 		$133K Buy
+14,360
New +$112K ﹤0.01% 4012

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commonwealth Equity Services's OCUL Position: Q2 2026 in Review

Commonwealth Equity Services increased its Ocular Therapeutix (OCUL) stake by 86% in Q2 2026, buying an estimated $81.3K and bringing the position to 19,417 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #4143.

Commonwealth Equity Services first reported a position in OCUL in Q2 2025 and has held it in 5 quarters since. 263 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Commonwealth Equity Services held 19,417 shares of Ocular Therapeutix worth $191K as of Q2 2026.
  • Commonwealth Equity Services bought 8,970 Ocular Therapeutix shares in Q2 2026, an estimated $81.3K.
  • Ocular Therapeutix made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4143 holding.
  • Commonwealth Equity Services first reported a position in Ocular Therapeutix in Q2 2025 and has held it in 5 quarters since.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.